Northwestern Medicine scientists have uncovered molecular mechanisms underlying lymphatic valve development, a discovery which could prove useful in treating lymphedema, according to a study published in The Journal of Clinical Investigation.
Month: July 2024
CAR T-cell therapy is an effective treatment for aggressive subtypes of follicular lymphoma, according to a clinical trial published in Nature Medicine.
The Feinberg Physician Assistant Program’s Class of 2026 recently celebrated the beginning of their medical journey with a white coat ceremony.
In its latest annual Best Hospitals rankings, U.S. News & World Report has once again recognized Northwestern Medicine hospitals as some of the best in the nation.
Subcutaneous delivery of an anti-TNF inhibitor therapy improved remission rates compared to placebo in patients with moderate-to-severe Crohn’s disease and ulcerative colitis who previously completed intravenous anti-TNF therapy, according to clinical trial results published in the journal Gastroenterology.
New Northwestern research shows that being near and having more exposure to urban green space and blue (water) space is linked to lower odds of having coronary artery calcification in middle age.
RNA modifications could serve as a therapeutic target for certain types of cancer, according to a new study published in Molecular Cell which sheds new light on the complex process underlying RNA transcription.
Scientists have discovered a molecular defect that promotes the pathologic immune response in lupus and demonstrated that reversing the defect may potentially reverse the disease.
Northwestern Medicine investigators have discovered novel protein mechanisms that promote the rapid spread of Vibrio vulnificus, a rare but lethal bacteria that can cause vibriosis and sepsis, according to findings published in Proceedings of the National Academy of Sciences.
V. Craig Jordan, PhD, the groundbreaking pharmacologist known as the “father” of breast cancer drug Tamoxifen, has died at 76.